Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective
Jiaxing Wang, Duane D. Miller, Wěi Li
Drug Discovery Today (2021) Vol. 27, Iss. 3, pp. 759-776
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 27
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site
Lun Tan, Chengyong Wu, Jifa Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3588-3620
Closed Access | Times Cited: 24
Genotoxic effects and mitosis aberrations of chromium (VI) on root cells of Vicia faba and its molecular docking analysis
Mohammed Bouhadi, Oussama Abchır, Imane Yamari, et al.
Plant Physiology and Biochemistry (2024) Vol. 207, pp. 108361-108361
Closed Access | Times Cited: 8
Structure-based discovery and rational design of microtubule-targeting agents
Michel O. Steinmetz, A.E. Prota
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102845-102845
Open Access | Times Cited: 5
Dual-target inhibitors of colchicine binding site for cancer treatment
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1154-1154
Open Access | Times Cited: 5
Isolation, cytotoxicity evaluation, and molecular docking of 3,4,3’-tri- O -methylflavellagic acid from Anogeissus leiocarpus (DC.) Guill. & Perr. root
Yemi A. Adekunle, Babatunde B. Samuel, Chinemenma M. Ezeude, et al.
Natural Product Research (2025), pp. 1-8
Open Access
Alkaloids Derived from Tyrosine: Phenethylisoquinoline (Colchicine)
Mihir Halder, Pijush Paul, Sumita Jha
Springer eBooks (2025), pp. 1-36
Closed Access
Discovery of a novel microtubule destabilizing agent targeting the colchicine site based on molecular docking
Jinhui Cai, Miao He, Yingying Wang, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116804-116804
Closed Access
Macrocarpal I induces immunogenic cell death and synergizes with immune checkpoint inhibition by targeting tubulin and PARP1 in colorectal cancer
Yaxin Zhang, Huali Li, Yali Zhao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Design, synthesis, and bioevaluation of 1 h -pyrrolo[3,2- c ]pyridine derivatives as colchicine-binding site inhibitors with potent anticancer activities
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction
Jiafu Leng, Yongjun Zhao, Shifang Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 3144-3166
Closed Access | Times Cited: 4
SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis
Shanshan Deng, Souvik Banerjee, Hao Chen, et al.
Cancer Letters (2022) Vol. 555, pp. 216046-216046
Open Access | Times Cited: 17
Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents
Laura Gallego‐Yerga, Valentı́n Ceña, Rafael Peláez
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1698-1698
Open Access | Times Cited: 8
Target Identification and Mechanistic Characterization of Indole Terpenoid Mimics: Proper Spindle Microtubule Assembly Is Essential for Cdh1‐Mediated Proteolysis of CENP‐A
Yan Peng, Yumeng Zhang, Fang Ruan, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 2
Discovery and mechanistic insights into thieno[3,2-d]pyrimidine and heterocyclic fused pyrimidines inhibitors targeting tubulin for cancer therapy
Chengyong Wu, Lele Zhang, Zhilan Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116649-116649
Closed Access | Times Cited: 2
Discovery of novel thiophene[3,2-d]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma
Chenglong Xu, Chengyong Wu, Ling Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116791-116791
Closed Access | Times Cited: 2
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation
Ateyatallah Aljuhani, Mohamed S. Nafie, Nader R. Albujuq, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107827-107827
Closed Access | Times Cited: 2
Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors
Jifa Zhang, Lun Tan, Chengyong Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115085-115085
Closed Access | Times Cited: 7
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
Yi‐Fong Chen, Bashir Lawal, Li‐Jiau Huang, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 555-555
Open Access | Times Cited: 7
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo
Satyanarayana Pochampally, Kelli L. Hartman, Rui Wang, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 526-545
Open Access | Times Cited: 7
Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells
Aysha Alneyadi, Zohra Nausheen Nizami, Hanan E. Aburawi, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2682-2682
Open Access | Times Cited: 6
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach
Roxana-Maria Amărandi, Cristina M. Al Matarneh, Lăcrămioara Popovici, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 865-865
Open Access | Times Cited: 6
Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors
Yuchen Tan, Han Hu, Wenjian Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115881-115881
Closed Access | Times Cited: 6
Identification and validation of novel microtubule suppressors with an imidazopyridine scaffold through structure-based virtual screening and docking
Samia A. Elseginy, A. Sofia F. Oliveira, Deborah K. Shoemark, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 8, pp. 929-943
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top